Skip to menu Skip to content Skip to footer

2002

Journal Article

Neutrophil dysplasia characterised by a pseudo-Pelger-Huet anomaly occurring with the use of mycophenolate mofetil and ganciclovir following renal transplantation: a report of five cases

Kennedy, Glen A., Kay, Troy D., Johnson, D. W., Hawley, Carmel M., Campbell, Scott B., Isbel, Nikky M.., Marlton, Paula, Cobcroft, Ralph, Gill, Devinder and Cull, Gavin (2002). Neutrophil dysplasia characterised by a pseudo-Pelger-Huet anomaly occurring with the use of mycophenolate mofetil and ganciclovir following renal transplantation: a report of five cases. Pathology, 34 (3), 263-266. doi: 10.1080/0031302022013136

Neutrophil dysplasia characterised by a pseudo-Pelger-Huet anomaly occurring with the use of mycophenolate mofetil and ganciclovir following renal transplantation: a report of five cases

2002

Journal Article

Is mycophenolate mofetil less safe than azathioprine in elderly renal transplant recipients?

Johnson, David W., Nicol, David L., Purdie, David M., Preston, John M., Brown, Allison M., Hawley, Carmel M., Campbell, Scott B., Wall, Darryl, Griffin, Anthony D. and Isbel, Nicole M. (2002). Is mycophenolate mofetil less safe than azathioprine in elderly renal transplant recipients?. Transplantation, 73 (7), 1158-1163.

Is mycophenolate mofetil less safe than azathioprine in elderly renal transplant recipients?

2002

Conference Publication

Is mycophenolate mofetil (MMF) less safe than azathioprine in older renal transplant patients?

Johnson, D. W., Nicol, D., Campbell, S. B., Petrie, J., Hawley, C. M. and Isbel, N. M. (2002). Is mycophenolate mofetil (MMF) less safe than azathioprine in older renal transplant patients?. Australian and New Zealand Society of Nephrology 37th Annual Scientific Meeting, Darwin, N. T., 5th - 7th September, 2001. Carlton, Victoria: Blackwell Science. doi: 10.1046/j.1440-1797.2002.00007-1-89.x

Is mycophenolate mofetil (MMF) less safe than azathioprine in older renal transplant patients?

2002

Conference Publication

Neutrophil Dysplasia Characterized by the Acquired Pelger-Huet Anomaly occurring with the Combination of Mycophenolate Mofetil and Ganciclovir Post Renal Transplantation: A Report of 5 Cases

Kay, T. D., Kennedy, G. A., Hawley, C. M., Campbell, S. B., Isbel, N. M., Marlton, P., Cobcroft, R., Gill, D., Cull, G. and Johnson, D. W. (2002). Neutrophil Dysplasia Characterized by the Acquired Pelger-Huet Anomaly occurring with the Combination of Mycophenolate Mofetil and Ganciclovir Post Renal Transplantation: A Report of 5 Cases. Australian and New Zealand Society of Nephrology 37th Annual Scientific Meeting, Darwin, NT Australia, 5 - 7 September 2001. Richmond, VIC Australia: Wiley-Blackwell. doi: 10.1046/j.1440-1797.2002.00007-1-83.x

Neutrophil Dysplasia Characterized by the Acquired Pelger-Huet Anomaly occurring with the Combination of Mycophenolate Mofetil and Ganciclovir Post Renal Transplantation: A Report of 5 Cases

2002

Conference Publication

Acute rejection is more common and severe in live donor than cadeveric donor kidney transplants

Johnson, D. W., Isbel, N. M., Hawley, C. M., Nicol, D. L. and Campbell, S. B. (2002). Acute rejection is more common and severe in live donor than cadeveric donor kidney transplants. Australian and New Zealand Society of Nephrology 37th Annual Scientific Meeting, Darwin, N.T., 5-7 September 2001. Carlton, Vic.: Blackwell Science. doi: 10.1046/j.1440-1797.2002.00007-1-110.x

Acute rejection is more common and severe in live donor than cadeveric donor kidney transplants

2002

Conference Publication

The effect of obesity on renal transplant outcomes

Johnson, D. W., Isbel, N., Kay, T. D., Hawley, C., Campbell, S. B. and Nicol, D. L. (2002). The effect of obesity on renal transplant outcomes. Australian and New Zealand Society of Nephrology 37th Annual Scientific Meeting, Darwin, N. T., 5th - 7th September, 2001. Carlton, Victoria: Blackwell Science. doi: 10.1046/j.1440-1797.2002.00007-1-39.x

The effect of obesity on renal transplant outcomes

2002

Conference Publication

A cross-over trial comparing intravenous (IV) and oral iron supplementation in erythropoietin (EPO) - treated peritoneal dialysis (PD) patients

Johnson, David W., Herzig, Karen A., Campbell, Scott Bryan, Hawley, Carmel M. and Isbel, Nicole M. (2002). A cross-over trial comparing intravenous (IV) and oral iron supplementation in erythropoietin (EPO) - treated peritoneal dialysis (PD) patients. 37th Annual Scientific Meeting of the Australian and New Zealand Society of Nephrology, Darwin, 5th - 7th September, 2001. Carlton, Victoria: Blackwell Science. doi: 10.1046/j.1440-1797.2002.00007-1-63.x

A cross-over trial comparing intravenous (IV) and oral iron supplementation in erythropoietin (EPO) - treated peritoneal dialysis (PD) patients

2002

Conference Publication

Macrophage-colony stimulating factor (M-CSF): A risk factor for atherosclerosis in uraemia?

Isbel, N. M., Fathi, R., Kennedy, R., Haluska, B., Short, L., Hawley, C. M., Campbell, S. B., Marwick, T. and Johnson, D. W. (2002). Macrophage-colony stimulating factor (M-CSF): A risk factor for atherosclerosis in uraemia?. 37th Annual Scientific Meeting of the Australian and New Zealand Society of Nephrology, Darwin, N.T., 5th - 7th September, 2001. Carlton, Victoria: Blackwell Science. doi: 10.1046/j.1440-1797.2002.00007-1-140.x

Macrophage-colony stimulating factor (M-CSF): A risk factor for atherosclerosis in uraemia?

2001

Journal Article

Oral versus intravenous iron supplementation in peritoneal dialysis patients

Johnson, David W., Herzig, Karen A., Gissane, Ruth, Campbell, Scott B., Hawley, Carmel M. and Isbel, Nicole M. (2001). Oral versus intravenous iron supplementation in peritoneal dialysis patients. Peritoneal Dialysis International, 21 (SUPPL. 3)

Oral versus intravenous iron supplementation in peritoneal dialysis patients

2001

Journal Article

Holistic care in hospital patients

Hawley, CM (2001). Holistic care in hospital patients. Medical Journal of Australia, 175 (6), 292-293.

Holistic care in hospital patients

2001

Journal Article

A prospective crossover trial comparing intermittent intravenous and continuous oral iron supplements in peritoneal dialysis patients

Johnson, David W., Herzig, Karen A., Gissane, Ruth, Campbell, Scott B., Hawley, Carmel M. and Isbel, Nicole M. (2001). A prospective crossover trial comparing intermittent intravenous and continuous oral iron supplements in peritoneal dialysis patients. Nephrology Dialysis Transplantation, 16 (9), 1879-1884. doi: 10.1093/ndt/16.9.1879

A prospective crossover trial comparing intermittent intravenous and continuous oral iron supplements in peritoneal dialysis patients

2001

Journal Article

Is C-reactive protein a useful predictor of outcome in peritoneal dialysis patients?

Herzig, K. A., Purdie, D. M., Chang, W., Brown, A. M., Hawley, C. M., Campbell, S. B., Sturtevant, J. M., Isbel, N. M., Nicol, D. L. and Johnson, D. W. (2001). Is C-reactive protein a useful predictor of outcome in peritoneal dialysis patients?. Journal of the American Society of Nephrology, 12 (4), 814-821.

Is C-reactive protein a useful predictor of outcome in peritoneal dialysis patients?

2001

Journal Article

Role of cytokine gene polymorphisms in acute rejection and renal impairment after liver transplantation

Jonsson, Julie R., Hong, Cui, Purdie, David M., Hawley, Carmel, Isbel, Nicky, Butler, Maree, Balderson, Glenda A., Clouston, Andrew D., Pandeya, Nirmala, Stuart, Katherine, Edwards-Smith, Catherine, Crawford, Darrel H., Fawcett, Jonathon and Powell, Elizabeth E. (2001). Role of cytokine gene polymorphisms in acute rejection and renal impairment after liver transplantation. Liver Transplantation, 7 (3), 255-263. doi: 10.1053/jlts.2001.22450

Role of cytokine gene polymorphisms in acute rejection and renal impairment after liver transplantation

2001

Conference Publication

Oral versus intravenous iron supplementation in peritoneal dialysis patients

Johnson, D. W., Herzig, K. A., Gissane, R., Campbell, S. B., Hawley, C. M. and Isbel, N. M. (2001). Oral versus intravenous iron supplementation in peritoneal dialysis patients. 9th Congress of the International Society of Peritoneal Dialysis, Montreal, QC, Canada, 26-29 June 2001. Thousand Oaks, CA, United States: Sage Publications. doi: 10.1177/089686080102103S41

Oral versus intravenous iron supplementation in peritoneal dialysis patients

2000

Journal Article

Novel Surveillance and Cure of A Donor-Transmitted Lymphoma in A Renal Allograft Recipient

Herzig, Karen A., Falk, Michael C., Jonsson, Julie R., Axelsen, Roy A., Griffin, Anthony D., Hawley, Carmel M., Rigby, Russell J., Cobcroft, Ralph, Nicol, David L., Powell, Elizabeth E. and Johnson, David W. (2000). Novel Surveillance and Cure of A Donor-Transmitted Lymphoma in A Renal Allograft Recipient. Transplantation, 70 (1), 149-152.

Novel Surveillance and Cure of A Donor-Transmitted Lymphoma in A Renal Allograft Recipient

2000

Journal Article

Alpha-1-antitrypsin phenotypes in patients with renal arterial fibromuscular dysplasia

Bofinger, A., Hawley, C., Fisher, P., Daunt, N., Stowasser, M. and Gordon, Richard D. (2000). Alpha-1-antitrypsin phenotypes in patients with renal arterial fibromuscular dysplasia. Journal of Human Hypertension, 14 (2), 91-94.

Alpha-1-antitrypsin phenotypes in patients with renal arterial fibromuscular dysplasia

2000

Journal Article

Alpha-1-antitrypsin phenotypes in patients with renal arterial fibromuscular dysplasia

Bofinger, A., Hawley, C., Fisher, P., Daunt, N., Stowasser, M. and Gordon, R. (2000). Alpha-1-antitrypsin phenotypes in patients with renal arterial fibromuscular dysplasia. Journal of Human Hypertension, 14 (2), 91-94. doi: 10.1038/sj.jhh.1000935

Alpha-1-antitrypsin phenotypes in patients with renal arterial fibromuscular dysplasia

2000

Journal Article

Is obesity a favorable prognostic factor in peritoneal dialysis patients?

Johnson, David W., Herzig, Karen A., Purdie, David M., Chang, Wendy, Brown, Allison M., Rigby, Russell J., Campbell, Scott B., Nicol, David L. and Hawley, Carmel M. (2000). Is obesity a favorable prognostic factor in peritoneal dialysis patients?. Peritoneal dialysis international, 20 (6), 715-721.

Is obesity a favorable prognostic factor in peritoneal dialysis patients?

2000

Conference Publication

Novel surveillance and cure of a donor-transmitted lymphoma in a renal allograft recipient

Herzig, K., Falk, M., Jonsson, J. R., Axelsen, R., Griffin, A., Hawley, C. M., Cobcroft, R., Powell, E. and Johnson, D. W. (2000). Novel surveillance and cure of a donor-transmitted lymphoma in a renal allograft recipient. 36th Annual Scientific Meeting of the A&NZ Society of Nephrology, Melbourne, 15-17 March, 2000.

Novel surveillance and cure of a donor-transmitted lymphoma in a renal allograft recipient

2000

Conference Publication

Obesity is a favourable prognostic factor in peritoneal dialyisi (PD) patients

Johnson, D. W., Herzig, K., Purdie, D., Chang, W., Brown, A. M., Campbell, S. B., Nicol, D. L. and Hawley, C. M. (2000). Obesity is a favourable prognostic factor in peritoneal dialyisi (PD) patients. Melbourne, 15-17 March 2000.

Obesity is a favourable prognostic factor in peritoneal dialyisi (PD) patients